COMPASS-NMD.EU: Keyword Density Checker

Total words: 1327 | 2-word phrases: 343 | 3-word phrases: 368 | 4-word phrases: 383

PAGE INFO

Title	Try to keep the title under 60 characters (23 characters) The CoMPaSS-NMD project
Description	Try to keep the meta description between 50 - 160 characters (237 characters) Towards improving the life quality of Hereditary Neuromuscular Disease (HNMDs) patients and their caregivers, thanks to the adoption of a new AI-based multidimensional approach for better and faster diagnosys and personalized treatments.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	the european union	5	1.36%
2	patients affected by	4	1.09%
3	the clinical research	4	1.09%
4	by hereditary neuromuscular	4	1.09%
5	affected by hereditary	4	1.09%
6	in the clinical	3	0.82%
7	healthcare professionals to	3	0.82%
8	hereditary neuromuscular diseases	3	0.82%
9	of the european	3	0.82%
10	join us and	2	0.54%
11	ml the study	2	0.54%
12	the study aims	2	0.54%
13	study aims to	2	0.54%
14	aims to provide	2	0.54%
15	to provide new	2	0.54%
16	integrate different clinical	2	0.54%
17	those of the	2	0.54%
18	learning ml the	2	0.54%
19	in the knowledge	2	0.54%
20	the knowledge of	2	0.54%
21	knowledge of the	2	0.54%
22	of the pathogenetic	2	0.54%
23	the pathogenetic and	2	0.54%
24	pathogenetic and transmission	2	0.54%
25	scientific community as	2	0.54%
26	and machine learning	2	0.54%
27	machine learning ml	2	0.54%
28	and the scientific	2	0.54%
29	ai and machine	2	0.54%
30	well as people	2	0.54%

#	Keyword	Frequency	Density
1	affected by hereditary neuromuscular	4	1.04%
2	by hereditary neuromuscular diseases	3	0.78%
3	of the european union	3	0.78%
4	of the pathogenetic and	2	0.52%
5	the pathogenetic and transmission	2	0.52%
6	the clinical research of	2	0.52%
7	in the clinical research	2	0.52%
8	participate in the clinical	2	0.52%
9	and participate in the	2	0.52%
10	us and participate in	2	0.52%
11	leading to a more	2	0.52%
12	hnmds leading to a	2	0.52%
13	to a more accurate	2	0.52%
14	a more accurate diagnosis	2	0.52%
15	more accurate diagnosis thus	2	0.52%
16	join us and participate	2	0.52%
17	prognosis which is often	2	0.52%
18	which is often difficult	2	0.52%
19	is often difficult to	2	0.52%
20	often difficult to predict	2	0.52%
21	knowledge of the pathogenetic	2	0.52%
22	the knowledge of the	2	0.52%
23	in the knowledge of	2	0.52%
24	the use of artificial	2	0.52%
25	hereditary neuromuscular diseases hnmds	2	0.52%
26	the application of methods	2	0.52%
27	application of methods based	2	0.52%
28	of methods based on	2	0.52%
29	methods based on the	2	0.52%
30	based on the use	2	0.52%
31	on the use of	2	0.52%
32	ai and machine learning	2	0.52%
33	more about the clinical	2	0.52%
34	and machine learning ml	2	0.52%
35	standard of care currently	2	0.52%
36	learning ml the study	2	0.52%
37	ml the study aims	2	0.52%
38	the study aims to	2	0.52%
39	study aims to provide	2	0.52%
40	aims to provide new	2	0.52%

#	URL	Whois	Check
1	https://www.linkedin.com/company/compass-nmd	Whois	linkedin.com
2	https://twitter.com/compass_nmd	Whois	twitter.com
3	https://www.facebook.com/compassNMD	Whois	facebook.com
4	https://www.linkedin.com/company/compass-nmd/	Whois	linkedin.com
5	https://www.linkedin.com/company/compass-nmd/	Whois	linkedin.com
6	https://docs.google.com/forms/d/e/1FAIpQLSeF3hEFMIa2uNFyNv6RDMRBRYsbbCrVHGKryCWL7QH48QKO5Q/viewform?usp=sf_link	Whois	google.com
7	https://docs.google.com/forms/d/e/1FAIpQLSeF3hEFMIa2uNFyNv6RDMRBRYsbbCrVHGKryCWL7QH48QKO5Q/viewform?usp=sf_link	Whois	google.com
8	https://www.linkedin.com/company/compass-nmd	Whois	linkedin.com
9	https://twitter.com/compass_nmd	Whois	twitter.com
10	https://www.facebook.com/compassNMD	Whois	facebook.com
11	https://dblue.it/en/	Whois	dblue.it
12	https://www.iubenda.com/privacy-policy/34547749	Whois	iubenda.com
13	https://www.iubenda.com/privacy-policy/34547749/cookie-policy	Whois	iubenda.com
14	https://www.iubenda.com/terms-and-conditions/34547749	Whois	iubenda.com